If lymph node involvement is confirmed within a client going through neoadjuvant therapy who is a potential candidate for focused axillary dissection (TAD), a marker needs to be inserted in the lymph node after biopsy. However, micrometastases are excluded from this possibility category. This also relates to the irradiation https://ferdinandt864tdp4.blog2freedom.com/profile